Substandard Rem-D Iv Infusion Batch No. Rd109 Manufactured By M/S. Liven Pharmaceuticals (Pvt.) Ltd., Kasur
Year: 2021
The Ethical Marketing to Healthcare Professionals Rules
Content missing
The Drug Pricing Policy, 2018
Content missing
The Medical Device Rules, 2017
Content missing
NOTIFICAITON No.F.8-9/2021-A-III (Coord).
In compliance of Prime Minister’s Office Islamabad U.O.No. I (45)/DS(PMDU-ly2l2l dated l4-10-2021. the Drug Regulatory
Authority of Pakistan (DRAP) is pleased to notify Mr. Aamar Latif. Deputy Director (Legal Affairs), DRAP, Islamabad to act as Facilitation Officer for dedicated facilitation desk of overseas Pakistanis.
Drug Product Recall: Biofen Suspension (Batch # SP-67) by M/S. Bio-Labs Private Limited, Islamabad
Biofen Suspension Reg. No. 046094, Batch No. SP-67 Manufactured By M/S. Bio-Labs Private Limited, Islamabad
Draft Guidelines for Establishment of Pharmaceutical Unit and Post License Changes (for Views/Comments)
Draft Guidelines for Imports & Exports of Therapeutic Goods (for Views/Comments of stakeholders)
Drug Product Recall: Blomox Forte Suspension (Batch #PF-045) by M/s Bloom Pharmaceuticals (Pvt.) Ltd. Hattar
Submission of Deficient Information / Documents (Enlistment Evaluation Committee (EEC) 92nd meeting held on 30th July, 2021)
The applications of following applicants were placed before the Enlistment Evaluation Committee (EEC) in its 92nd meeting held on 30th July, 2021 and the same have been deferred being deficient of the information / documents as specified in column (3) of the Table below which may be furnished within 20 days of uploading of this letter on official website of DRAP along with soft data as per Annexed Format at the end of this letter/document.